Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
(αS)-α,4-Dimethyl-2'-(trifluoromethyl)[3,4'-bipyridine]-6-methanamine is a compound involved in the discovery and evaluation of the clinical candidate IDH305, a brain penetrant mutant 1DH1 inhibitor.